Zantac Recall Widens as Sanofi Pulls Its Drug Over Carcinogen Fears
The French drug maker Sanofi said Friday that it was recalling the over-the-counter heartburn drug Zantac in the United States and Canada, a month after the Food and Drug Administration first alerted the public that versions of the drug contained low levels of a cancer-causing contaminant. Several manufacturers of generic versions of Zantac, called ranitidine,…